At Dynacare, our vision is to be Canada’s health and wellness solutions leader. As part of our continuous efforts to enhance our testing platforms and support customer care, Dynacare is implementing a new state-of-the-art chemistry platform in its Winnipeg laboratory on March 23, 2020. This platform will increase our testing capabilities and allow us to manage increases in healthcare demands over the years to come. Additionally, it will enable automated detection of common interferences (hemolysis, icterus, and lipemia).
As part of the transition to the new platform, Dynacare has reviewed the current reference intervals and will be making the following changes.
Partner Update - Chemistry and Immunoassay Testing For testing performed in Manitoba only